0001214659-13-002783.txt : 20130515 0001214659-13-002783.hdr.sgml : 20130515 20130515163049 ACCESSION NUMBER: 0001214659-13-002783 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130515 DATE AS OF CHANGE: 20130515 EFFECTIVENESS DATE: 20130515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001232621 IRS NUMBER: 461592449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14822 FILM NUMBER: 13847630 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-200-3830 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 510 CITY: SAN DIEGO STATE: CA ZIP: 92121 13F-HR 1 f5913213fhr.txt REPORT FOR THE QUARTER ENDED MARCH 31, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2013 Check here if Amendment [ ]; Amendment Number: __ This Amendment (Check only one): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Tang Capital Management, LLC Address: 4747 Executive Drive, Suite 510, San Diego, CA 92121 Form 13F File Number: 28-14822 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin C. Tang Title: Managing Director of Tang Capital Management, LLC Phone: 858-200-3830 Signature, Place, and Date of Signing: /s/ Kevin C. Tang San Diego, CA May 15, 2013 ----------------------- ------------------------ ------------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE REPORT SUMMARY: NUMBER OF OTHER INCLUDED MANAGERS: 1 FORM 13F INFORMATION TABLE ENTRY TOTAL: 24 FORM 13F INFORMATION TABLE VALUE TOTAL: 306,205 (thousands) LIST OF OTHER INCLUDED MANAGERS: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. 1 Kevin C. Tang 28-14818

FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE AFFYMAX INC COM 00826A109 723 525,990 SH SOLE 525,990 0 0 ANTHERA PHARMACEUTICALS INC COM 03674U102 3,507 5,313,917 SH SOLE 5,313,917 0 0 ARENA PHARMACEUTICALS INC COM 040047102 3,922 477,683 SH SOLE 477,683 0 0 BIOMARIN PHARMACEUTICAL INC COM 09061G101 11,269 180,995 SH SOLE 180,995 0 0 CYCLACEL PHARMACEUTICALS INC COM 23254L306 4,277 765,198 SH SOLE 765,198 0 0 DENDREON CORP NOTE 2.875% 1/15/16 24823QAC1 20,814 26,515,000 PRN SOLE 26,515,000 0 0 DENDREON CORP COM 24823Q107 377 79,600 SH SHARED- DEFINED 1 0 79,600 0 DEPOMED INC COM 249908104 16,060 2,735,931 SH SOLE 2,735,931 0 0 ENDOCYTE INC COM 29269A102 5,799 465,763 SH SOLE 465,763 0 0 INTERMUNE INC NOTE 2.500% 9/15/18 45884XAE3 14,334 17,000,000 PRN SOLE 17,000,000 0 0 IRONWOOD PHARMACEUTICALS INC COM 46333X108 10,971 600,000 SH SOLE 600,000 0 0 MANNKIND CORP NOTE 3.750% 12/15/13 56400PAA0 36,878 41,494,000 PRN SOLE 41,494,000 0 0 MANNKIND CORP COM 56400P201 5,619 1,657,384 SH SOLE 1,657,384 0 0 NAVIDEA BIOPHARMACEUTICALS INC COM 63937X103 2,623 968,079 SH SOLE 968,079 0 0 NEKTAR THERAPEUTICS COM 640268108 11,490 1,044,544 SH SOLE 1,044,544 0 0 ONCOGENEX PHARMACEUTICALS INC COM 68230A106 10,572 933,100 SH SOLE 933,100 0 0 ONCOTHYREON INC COM 682324108 2,044 984,980 SH SOLE 984,980 0 0 OPKO HEALTH INC NOTE 3.0% 2/1/33 68375NAB9 32,124 29,500,000 PRN SOLE 29,500,000 0 0 PACIRA PHARMACEUTICALS INC NOTE 3.25% 2/1/19 695127AA8 32,210 23,500,000 PRN SOLE 23,500,000 0 0 PDL BIOPHARMA INC NOTE 2.875% 2/15/15 69329YAE4 48,501 37,474,000 PRN SOLE 37,474,000 0 0 QUESTCOR PHARMACEUTICALS INC COM 74835Y101 1,627 50,000 SH SOLE 50,000 0 0 SAVIENT PHARMACEUTICALS INC NOTE 4.750% 2/1/18 80517QAA8 8,229 30,476,000 PRN SOLE 30,476,000 0 0 SALIX PHARMACEUTICALS INC COM 795435106 15,354 300,000 SH SOLE 300,000 0 0 VANDA PHARMACEUTICALS INC COM 921659108 6,881 1,755,324 SH SOLE 1,755,324 0 0